Articles

The comprehensive landscape of TTMV::RARA fusion-driven acute myeloid leukemia: from viral integration mechanisms to clinical outcomes

Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing
Biomedical big data center, the First Ailiated Hospital, Zhejiang University School of Medicine, Hangzhou
Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing
Institute for Cancer, Chinese Institutes for Medical Research (CIMR), Beijing
Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
Institute for Cancer, Chinese Institutes for Medical Research (CIMR), Beijing
Pediatric hematology and oncology of Xingtai People's Hospital, Hebei
Department of Hematology, The Third People's Hospital of Zhengzhou, Zhengzhou
Institute for Cancer, Chinese Institutes for Medical Research (CIMR), Beijing
Department of Hematology, The First College of Clinical Medicine Science, China Three Gorges University affiliated Yichang Central People's Hospital, Yichang, Hubei
National Clinical Research Center for Hematologic Diseases, The First Ailiated Hospital of Soochow University, Jiangsu Institute of Hematology, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou
Department of Hematology, Zigong First People’s Hospital, Zigong
Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing
Institute for Cancer, Chinese Institutes for Medical Research (CIMR), Beijing
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical, Beijing
Department of Hematology, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai
Department of Hematology, The First College of Clinical Medicine Science, China Three Gorges University affiliated Yichang Central People's Hospital, Yichang, Hubei
Department of Hematology, The Third People's Hospital of Zhengzhou, Zhengzhou
Pediatric hematology and oncology of Xingtai People's Hospital, Hebei
Department of Hematology, Zigong First People’s Hospital, Zigong
Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing
Department of Pediatrics, Peking University People's Hospital, Beijing
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical, Beijing
Department of Hematology, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai
National Clinical Research Center for Hematologic Diseases, The First Ailiated Hospital of Soochow University, Jiangsu Institute of Hematology, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou
Department of Pathology, University of California San Diego, La Jolla, California
Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
Biomedical big data center, the First Ailiated Hospital, Zhejiang University School of Medicine, Hangzhou
Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China; Institute for Cancer, Chinese Institutes for Medical Research (CIMR), Beijing
Haematologica Early view Nov 13, 2025 https://doi.org/10.3324/haematol.2025.288721